Effect of citalopram on plasma levels of oral theophylline

Clinical Therapeutics

Volumn 22, Issue 12, 2000, Pages 1494-1501

  Møller, Svend Erik ^a   Larsen, Frank ^a   Pitsiu, Maria ^b   Rolan, Paul E ^b  

^a H LUNDBECK A S   (Denmark)

^b Medeval Ltd   (United Kingdom)

Author keywords

Citalopram; CYP1A2; Drug interaction; Selective serotonin reuptake inhibitor; Theophylline

Indexed keywords

CITALOPRAM; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; BIOAVAILABILITY; BLOOD SAMPLING; CLINICAL ARTICLE; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG UPTAKE; ENZYME METABOLISM; FATIGUE; FEMALE; HUMAN; MALE; NAUSEA;

EID: 0034528084     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)83047-7     Document Type: Article

References (18)

1. Citalopram - Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity
2. Kinetics of citalopram in man: Plasma levels in patients
3. The kinetics of citalopram: Single and multiple dose studies in man
4. Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes
5. Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms
6. Human cytochromes and some newer antidepressants: Kinetics, metabolism, and drug interactions
7. Citalopram and desmethylcitalopram in vitro: Human cytochromes mediating transformation, and cytochrome inhibitory effects
8. Therapy
9. Characterization of human liver cytochromes P-450 involved in theophylline metabolism
10. Citalopram: A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression
11. The pharmacokinetics of citalopram
12. Drug interactions with newer antidepressants: Role of human cytochromes P450
13. Fluvoxamine is a potent inhibitor of cytochrome P4501A2
14. Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy
15. Toxic effects of theophylline caused by fluvoxamine